Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.
Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, van Zeben D, Dijkmans BA, Peeters AJ, Jacobs P, van den Brink HR, Schouten HJ, van der Heijde DM, Boonen A, van der Linden S. Boers M, et al. Among authors: van de laar ma, van denderen jc, van zeben d, van den brink hr, van der heijde dm, van der linden s. Lancet. 1997 Aug 2;350(9074):309-18. doi: 10.1016/S0140-6736(97)01300-7. Lancet. 1997. PMID: 9251634 Clinical Trial.
The main outcomes were the pooled index (a weighted change score of five disease activity measures) and the Sharp/Van der Heijde radiographic damage score in hands and feet. ...
The main outcomes were the pooled index (a weighted change score of five disease activity measures) and the Sharp/Van der Heijde radi …
COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention.
Landewé RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, van Denderen JC, Westedt ML, Peeters AJ, Dijkmans BA, Jacobs P, Boonen A, van der Heijde DM, van der Linden S. Landewé RB, et al. Among authors: van de laar ma, van denderen jc, van der heijde dm, van der linden s. Arthritis Rheum. 2002 Feb;46(2):347-56. doi: 10.1002/art.10083. Arthritis Rheum. 2002. PMID: 11840436 Clinical Trial.
Two independent assessors scored radiographs in sequence according to the Sharp/van der Heijde method. Outcomes were analyzed by generalized estimating equations on the basis of intent-to-treat, starting with data obtained at the last visit of the COBRA trial (56 weeks aft …
Two independent assessors scored radiographs in sequence according to the Sharp/van der Heijde method. Outcomes were analyzed by gene …
Efficacy and safety of mesalazine (Salofalk) in an open study of 20 patients with ankylosing spondylitis.
van Denderen JC, van der Horst-Bruinsma I, Bezemer PD, Dijkmans BA. van Denderen JC, et al. Among authors: van der horst bruinsma i. J Rheumatol. 2003 Jul;30(7):1558-60. J Rheumatol. 2003. PMID: 12858458 Clinical Trial.
Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis.
van Denderen JC, van der Paardt M, Nurmohamed MT, de Ryck YM, Dijkmans BA, van der Horst-Bruinsma IE. van Denderen JC, et al. Among authors: van der paardt m, van der horst bruinsma ie. Ann Rheum Dis. 2005 Dec;64(12):1761-4. doi: 10.1136/ard.2005.036491. Epub 2005 May 18. Ann Rheum Dis. 2005. PMID: 15901634 Free PMC article. Clinical Trial.
Immunogenicity does not influence treatment with etanercept in patients with ankylosing spondylitis.
de Vries MK, van der Horst-Bruinsma IE, Nurmohamed MT, Aarden LA, Stapel SO, Peters MJ, van Denderen JC, Dijkmans BA, Wolbink GJ. de Vries MK, et al. Among authors: van der horst bruinsma ie, van denderen jc. Ann Rheum Dis. 2009 Apr;68(4):531-5. doi: 10.1136/ard.2008.089979. Epub 2008 Mar 28. Ann Rheum Dis. 2009. PMID: 18375542
Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis.
van Tuyl LH, Boers M, Lems WF, Landewé RB, Han H, van der Linden S, van de Laar M, Westhovens R, van Denderen JC, Westedt ML, Peeters AJ, Jacobs P, Huizinga TW, van de Brink H, Dijkmans BA, Voskuyl AE. van Tuyl LH, et al. Among authors: van der linden s, van de laar m, van denderen jc, van de brink h. Ann Rheum Dis. 2010 May;69(5):807-12. doi: 10.1136/ard.2009.108027. Epub 2009 May 17. Ann Rheum Dis. 2010. PMID: 19451137 Clinical Trial.
What do we miss? ASAS non-responders on anti-TNF therapy show improvement in performance-based physical function.
van Weely SF, van Denderen JC, Steultjens MP, Nurmohamed MT, Dijkmans BA, Dekker J, van der Horst-Bruinsma IE. van Weely SF, et al. Among authors: van denderen jc. Rheumatology (Oxford). 2013 Oct;52(10):1884-9. doi: 10.1093/rheumatology/ket240. Epub 2013 Jul 17. Rheumatology (Oxford). 2013. PMID: 23864170
Adalimumab significantly reduces the recurrence rate of anterior uveitis in patients with ankylosing spondylitis.
van Denderen JC, Visman IM, Nurmohamed MT, Suttorp-Schulten MS, van der Horst-Bruinsma IE. van Denderen JC, et al. J Rheumatol. 2014 Sep;41(9):1843-8. doi: 10.3899/jrheum.131289. Epub 2014 Aug 1. J Rheumatol. 2014. PMID: 25086071
Etanercept Increases Bone Mineral Density in Ankylosing Spondylitis, but Does Not Prevent Vertebral Fractures: Results of a Prospective Observational Cohort Study.
van der Weijden MA, van Denderen JC, Lems WF, Nurmohamed MT, Dijkmans BA, van der Horst-Bruinsma IE. van der Weijden MA, et al. Among authors: van denderen jc. J Rheumatol. 2016 Apr;43(4):758-64. doi: 10.3899/jrheum.150857. Epub 2016 Feb 15. J Rheumatol. 2016. PMID: 26879348
Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab.
Ruwaard J, l'Ami MJ, Marsman AF, Kneepkens EL, van Denderen JC, van der Horst-Bruinsma IE, Nurmohamed MT, Wolbink G. Ruwaard J, et al. Among authors: van denderen jc. Scand J Rheumatol. 2018 Mar;47(2):122-126. doi: 10.1080/03009742.2017.1330419. Epub 2017 Jul 26. Scand J Rheumatol. 2018. PMID: 28745108
33 results
Jump to page
Feedback